Format
Sort by

Send to

Choose Destination

Search results

Items: 3

1.

Comparison of in vitro activities of tigecycline, doxycycline, and tetracycline against the spirochete Borrelia burgdorferi.

Ates L, Hanssen-Hübner C, Norris DE, Richter D, Kraiczy P, Hunfeld KP.

Ticks Tick Borne Dis. 2010 Mar;1(1):30-4. doi: 10.1016/j.ttbdis.2009.11.004. Epub 2010 Jan 7.

PMID:
21771509
2.

Mutational analyses of the BbCRASP-1 protein of Borrelia burgdorferi identify residues relevant for the architecture and binding of host complement regulators FHL-1 and factor H.

Kraiczy P, Hanssen-Hübner C, Kitiratschky V, Brenner C, Besier S, Brade V, Simon MM, Skerka C, Roversi P, Lea SM, Stevenson B, Wallich R, Zipfel PF.

Int J Med Microbiol. 2009 Apr;299(4):255-68. doi: 10.1016/j.ijmm.2008.09.002. Epub 2009 Jan 9.

PMID:
19138559
3.

In vitro susceptibility of Borrelia spielmanii to antimicrobial agents commonly used for treatment of Lyme disease.

Morgenstern K, Baljer G, Norris DE, Kraiczy P, Hanssen-Hübner C, Hunfeld KP.

Antimicrob Agents Chemother. 2009 Mar;53(3):1281-4. doi: 10.1128/AAC.01247-08. Epub 2008 Dec 15.

Supplemental Content

Loading ...
Support Center